CASI Pharmaceuticals (Formerly Known As EntreMed, Inc.)
9620 Medical Center Drive
CASI is a biopharmaceutical company focused on the acquisition, development, and commercialization of innovative therapeutics addressing CANCER and other unmet medical needs for the global market, with a focus on China and the U.S.
CEO: Ken Ren
CMO (Medical): Rong Chen
Please click here for clinical trial information.